NCT03615326 2025-12-11MK-3475-811Merck Sharp & Dohme LLCPhase 3 Completed738 enrolled 22 charts 7 FDA
NCT00770874 2019-06-21Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical CancerTaiho Pharmaceutical Co., Ltd.Phase 3 Completed375 enrolled 10 charts